CRISPR/Cas9 genome editing to treat sickle cell disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Príomhchruthaitheoir: | Ullah, Mohammad |
---|---|
Rannpháirtithe: | Islam, Farzana |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2023
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/19355 |
Míreanna comhchosúla
-
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
de réir: Maria, Amatul
Foilsithe / Cruthaithe: (2020) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
de réir: Shaikat, Mahdi Mubin
Foilsithe / Cruthaithe: (2023) -
A review on CRISPR-Cas system based applications in Oncology
de réir: Sadia, Mir
Foilsithe / Cruthaithe: (2022) -
A review on CRISPR Technology as an Antiviral Tool
de réir: Srishti, Sanjida Ahmed
Foilsithe / Cruthaithe: (2023) -
CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
de réir: Eva, Israt Ara Jannat
Foilsithe / Cruthaithe: (2023)